SecBot SecBot

MTRI

InMed Pharmaceuticals Inc.
Nasdaq· CIK 0001728328 Biotech & Drug Discovery
$19.87 +1.27 (+6.83%)
Nov 16 4:00 PM ET · prev $18.60
Market cap
$986.0M
Small cap
1 year
+20.4%
from $16.50 · Nov 17
30 days
+45.6%
from $13.65
52-week range
$6.15–19.87
at the high
Avg volume 20D
25.8K
Nov 12 spike 145.6K
Insider net
+$34.6K
1 buyer · 0 sellers · 12 mo
Filing reports
9
analyzed by SecBot
SecBot read MIXED 10 reports · 90 days
Balance 1 bearish · 0 bullish · 1 mixed · 8 neutral oldest → newest, height = score
Avg score ·High conf. 8/10

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $34.6K at an average $13.10. No open-market sales. Price is 52% above their cost.

  • TrendUPTREND

    39% above its 50-day average. New closing high $19.87 on Nov 16.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 13, 2026 SEC
Commodore Capital LP filed a Schedule 13G disclosing a 5.6% passive stake in Mentari Therapeutics (formerly InMed…
SC 13G · Impact 3/10
Nov 11, 2026 Trading halt
Halt Resumed: MTRI, trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-11-11T14:32:33.000Z | Resumed 2026-11-11T14:37:33.000Z
Nov 9, 2026 Press
Mentari Therapeutics announced management participation in three upcoming investor conferences in November 2026. This…
Impact 2/10
Nov 9, 2026 Insider
Shegog Todd was granted 37,000 shares
Director
Nov 9, 2026 Insider
Pernice Michelle Patricia was granted 37,000 shares
Director
Nov 9, 2026 Insider
Divis Gregory J was granted 1,560,599 shares
See Remarks
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$34.6K
bought · 1 insider
$0
sold · 0 insiders
+51.7%
vs their $13.10 cost
DateInsiderTypeValue
Nov 9, 2026
Shegog Todd
Director
Nov 9, 2026
AWARD37,000 sh
Nov 9, 2026
Pernice Michelle Patricia
Director
Nov 9, 2026
AWARD37,000 sh
Nov 9, 2026
Divis Gregory J
See Remarks
Nov 9, 2026
AWARD1,560,599 sh
Nov 9, 2026
Bruno Julianne
Director
Nov 9, 2026
AWARD37,000 sh
Nov 9, 2026
Seurer Jerad G.
See Remarks
Nov 9, 2026
AWARD257,000 sh
Nov 9, 2026
Hagen Brett R
See Remarks
Nov 9, 2026
AWARD171,000 sh
Nov 9, 2026
Sandler Laura Lee
Director
Nov 9, 2026
AWARD37,000 sh
Nov 5, 2026
ADAR1 Capital Management, LLC
10%+ Owner
Nov 5, 2026
BUY$34.6K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FY-$1.75-$1.75–-$1.75No data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA
Trading halts
Nov 11, 2026Volatility PauseResumed
Nov 9, 2026Volatility PauseResumed
Nov 9, 2026Volatility PauseResumed
Nov 9, 2026Volatility PauseResumed
Nov 9, 2026Volatility PauseResumed

SecBot reports

9 filings · 1 press release · 0 bullish · 1 bearish · 1 mixed · 7 neutral
All MTRI filing & press-release reports (10)